Bio-Techne Corp (NASDAQ: TECH) on Friday, plunged -2.38% from the previous trading day, before settling in for the closing price of $53.29. Within the past 52 weeks, TECH’s price has moved between $46.01 and $83.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 11.13% annually for the last half of the decade. The company achieved an average annual earnings per share of 7.27%. With a float of $154.99 million, this company’s outstanding shares have now reached $156.76 million.
In an organization with 3100 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 65.88%, operating margin of 14.22%, and the pretax margin is 13.48%.
Bio-Techne Corp (TECH) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Bio-Techne Corp is 1.13%, while institutional ownership is 104.89%. The most recent insider transaction that took place on Jun 09 ’25, was worth 63,705. In this transaction Director of this company sold 1,280 shares at a rate of $49.77, taking the stock ownership to the 1,976 shares. Before that another transaction happened on Jun 09 ’25, when Company’s Officer proposed sale 1,280 for $49.77, making the entire transaction worth $63,705.
Bio-Techne Corp (TECH) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 7.27% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.94% during the next five years compared to 11.13% growth over the previous five years of trading.
Bio-Techne Corp (NASDAQ: TECH) Trading Performance Indicators
Bio-Techne Corp (TECH) is currently performing well based on its current performance indicators. A quick ratio of 2.58 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.75. Likewise, its price to free cash flow for the trailing twelve months is 36.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.82, a number that is poised to hit 0.50 in the next quarter and is forecasted to reach 2.05 in one year’s time.
Technical Analysis of Bio-Techne Corp (TECH)
Let’s dig in a bit further. During the last 5-days, its volume was 1.45 million. That was inferior than the volume of 1.98 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 34.27%.
During the past 100 days, Bio-Techne Corp’s (TECH) raw stochastic average was set at 29.37%, which indicates a significant decrease from 37.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.90 in the past 14 days, which was lower than the 2.18 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $50.49, while its 200-day Moving Average is $63.23. However, in the short run, Bio-Techne Corp’s stock first resistance to watch stands at $53.36. Second resistance stands at $54.70. The third major resistance level sits at $55.51. If the price goes on to break the first support level at $51.21, it is likely to go to the next support level at $50.40. The third support level lies at $49.06 if the price breaches the second support level.
Bio-Techne Corp (NASDAQ: TECH) Key Stats
Market capitalization of the company is 8.16 billion based on 156,767K outstanding shares. Right now, sales total 1,159 M and income totals 168,110 K. The company made 316,180 K in profit during its latest quarter, and 22,590 K in sales during its previous quarter.
